跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
連結會在新分頁中打開
English
中文
在 臺北醫學大學 搜尋內容
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
醫學系
臺北醫學大學
醫學院
電話
+886-2-27361661#3111~3114
電子郵件
[email protected]
網站
http://medschool.tmu.edu.tw/main.php
郵寄地址
在地圖上顯示
No. 250 Wu-Xing Street
11031
Taipei
概覽
指紋
網路
專家檔案
(381)
專案
(3280)
研究成果
(17889)
資料集
(487)
活動
(6)
指紋
查看啟用 醫學系 的研究主題。這些主題標籤來自此機構會員的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Rat
100%
Cohort Study
61%
Malignant Neoplasm
61%
Inflammation
40%
Diseases
40%
Chronic Kidney Failure
34%
Protein Kinase B
32%
Reactive Oxygen Metabolite
31%
Neoplasm
30%
Cerebrovascular Accident
28%
Cytotoxicity
27%
Randomized Controlled Trial
27%
Liver Cell Carcinoma
25%
Lipopolysaccharide
24%
Antioxidant
24%
Nitric Oxide
22%
Diabetes Mellitus
22%
Epidermal Growth Factor Receptor
21%
Cardiovascular Disease
21%
Breast Cancer
21%
Adverse Event
21%
Lung Cancer
20%
Colorectal Carcinoma
20%
Lipid
19%
Mitogen Activated Protein Kinase
19%
Chemotherapy Regimens
19%
Nanoparticle
19%
Calcium Ion
18%
Brain Ischemia
18%
Western Blot
18%
Hypertension
17%
Congestive Heart Failure
17%
Infection
17%
Glucose
17%
Cytokine
17%
Chronic Obstructive Lung Disease
17%
Atrial Fibrillation
16%
Receptor
16%
Messenger RNA
16%
Phosphotransferase
16%
Nuclear Factor
15%
Maturity Onset Diabetes of the Young
15%
Non Small Cell Lung Cancer
15%
Tumor Necrosis Factor
15%
Prostate Cancer
15%
Prevalence
14%
Biological Marker
14%
Caspase 3
14%
Placebo
14%
Hemodialysis
13%
Cyclooxygenase 2
13%
Alternative Complement Pathway C3 C5 Convertase
12%
Carcinogenesis
12%
Anti-Inflammatory Drug
12%
Heme Oxygenase 1
12%
Interleukin 6
12%
Tumor Growth
12%
Antiplatelet
12%
Pneumonia
12%
Protein Kinase C
12%
Glioblastoma
11%
Arrhythmogenesis
11%
Schizophrenia
11%
Mouse Model
11%
microRNA
11%
Colon Carcinoma
11%
Peptide
10%
Cisplatin
10%
Inducible Nitric Oxide Synthase
10%
Cell Viability
10%
Therapeutic Effect
10%
Antiinfective Agent
10%
Influenza
10%
Angiotensin II
10%
Fibrosis
10%
Enzymes
10%
Vaccination
10%
Chitosan
10%
Rat Model
9%
Adenosine Triphosphate
9%
IC50
9%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
9%
Protein P53
9%
Leporidae
9%
Clinical Trial
9%
Asthma
9%
Lung Adenocarcinoma
9%
Metabolic Syndrome X
9%
End Stage Renal Disease
8%
Peroxisome Proliferator Activated Receptor
8%
Insulin
8%
Statin (Protein)
8%
Endothelin 1
8%
Recurrent Disease
8%
Comorbidity
8%
Pharmacokinetics
8%
Pathogenesis
8%
Gelatinase B
8%
Overall Survival
8%
Doxorubicin
8%
Medicine and Dentistry
Meta-Analysis
74%
Cohort Analysis
62%
Systematic Review
59%
Diseases
43%
Randomized Controlled Trial
42%
Odds Ratio
35%
Neoplasm
34%
Hazard Ratio
33%
Apoplexy
30%
Magnetic Resonance Imaging
25%
Chronic Kidney Disease
24%
Malignant Neoplasm
23%
Prevalence
20%
Retrospective Cohort Study
20%
Breast Cancer
20%
Hepatocellular Carcinoma
19%
Diabetes Mellitus
18%
Recurrent Disease
18%
Computer Assisted Tomography
18%
Radiation Therapy
18%
Cancer
18%
Lung
18%
Infection
18%
Overall Survival
18%
Diabetes
17%
Cardiovascular Disease
17%
Chemotherapy
16%
Maturity Onset Diabetes of the Young
16%
Tuberculosis
16%
Comorbidity
15%
Body Mass Index
15%
Inflammation
15%
Biological Marker
15%
Tumor
14%
Injection
14%
Bipolar Disorder
14%
In Vitro
14%
COVID-19
14%
Retrospective Study
14%
Brain Ischemia
14%
Logistic Regression Analysis
13%
Atrial Fibrillation
13%
Adverse Event
13%
Proportional Hazards Model
13%
Quality of Life
12%
Hypertension
12%
Obstructive Sleep Apnea
12%
Congestive Heart Failure
11%
Oral
11%
Case-Control Study
11%
Cardiovascular System
11%
Pediatrics
11%
Non Small Cell Lung Cancer
11%
Colorectal Carcinoma
11%
Pneumonia
10%
Supplementation
10%
Survival Rate
10%
Cancer Cell
10%
Surgeon
10%
Knee
10%
Schizophrenia
10%
Lung Cancer
10%
Asthma
10%
Epidermal Growth Factor Receptor
10%
Programmed Cell Death
10%
Hemodialysis
9%
Glucose
9%
Acute Kidney Injury
9%
Chemoradiotherapy
9%
Bleeding
9%
4 Iodo 2,5 Dimethoxyamphetamine
9%
Osteoporosis
9%
Observational Study
9%
Network Meta-Analysis
9%
Mortality Rate
9%
Chronic Obstructive Pulmonary Disease
9%
Rectum Cancer
9%
Urinary System
9%
End Stage Renal Disease
8%
Myocardial Infarction
8%
Biopsy Technique
8%
Laparoscopic Surgery
8%
Transitional Cell Carcinoma
8%
Bladder
8%
Placebo
8%
Health Care Cost
8%
Prognostic Factor
8%
Postoperative Complication
8%
Morbidity
8%
Pulmonary Vein
7%
Cerebral Hemorrhage
7%
Cross Sectional Study
7%
Area under the Curve
7%
Prostate Cancer
7%
Squamous Cell Carcinoma
7%
Artificial Intelligence
7%
Particular Matter 2.5
7%
Signal Transduction
7%
Neck
7%
Metabolic Syndrome
7%
Immunology and Microbiology
Infection
49%
Infectious Disease
48%
Lung
42%
Inflammation
33%
In Vitro
31%
Phosphotransferase
25%
Kinase
25%
Rat
24%
Programmed Cell Death
24%
Cancer Cell
24%
Macrophage
21%
Blood Plasma
18%
Interleukin 6
16%
Cytokine
16%
Prevalence
15%
Tumor Necrosis Factor
15%
Susceptibility
14%
Asthma
14%
Oxidative Stress
14%
Dioxygen
13%
Signal Transduction
13%
Cardiovascular System
12%
Gene Expression
12%
Autophagy
12%
COVID-19
11%
Upregulation
11%
Squamous Cell
10%
Endothelial Cells
10%
Cell Migration
10%
Cell Proliferation
10%
T Cell
10%
Interferon Type I
10%
Overall Survival
10%
Cytotoxicity
9%
Colorectal Carcinoma
9%
Monocyte
9%
Intestine Flora
9%
Interleukin 1
9%
Mouse Model
9%
Mesenchymal Stem Cell
9%
Antigen
8%
Immune Response
8%
Comorbidity
8%
Secretion (Process)
8%
Western Blot
8%
Dengue Virus
8%
Glucose
8%
Neutrophil
7%
phosphorylation
7%
Particulate Matter
7%
Viral Disease
7%
Inflammation Response
7%
Airway
7%
Blood Level
7%
Heme Oxygenase
7%
Minimum Inhibitory Concentration
7%
Ribonucleic Acid
7%
Dendritic Cell
7%
Interleukin 10
7%
Osteoarthritis
7%
C-Reactive Protein
6%
Klebsiella pneumoniae
6%
Cell Death
6%
Nitric Oxide Synthase
6%
down Regulation
6%
Antibiotic Resistance
6%
Hepatitis C Virus
6%
Inflammatory Arthritis
6%
Body Mass
6%
Pretreatment
6%
Severe Acute Respiratory Syndrome Coronavirus 2
6%
Caspase
6%
Platelet
6%
Survival Rate
6%
Hepatitis B Virus
6%
Staining
6%
Reperfusion
6%
Infectious Agent
6%
Protein Expression
5%
Hemodialysis
5%
Hepatitis C
5%
Regulatory T Cell
5%
Epidermal Growth Factor
5%
Immunocompetent Cell
5%
Mitogen
5%
Hepatitis B
5%
Epithelial Mesenchymal Transition
5%
Promoter Region
5%
Complement Factor B
5%
Glutamine
5%
P53
5%
Escherichia coli
5%
Carcinoma Cell
5%
TLR4
5%
Proinflammatory Cytokine
5%
Peptides
5%
Muscle
5%
Immunotherapy
5%
Fibroblast
5%
Chemokine
5%